Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOSEAL for Hemostasis in Primary Unilateral TKA
NCT01410240Phase 4Completed
- Sponsor
- Baxter
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of gelatin + thrombin in osteoarthritis (OA), sponsored by Baxter. Started Sep 2011; status: completed.
02
Drugs
gelatin + thrombin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01410240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410240.